Peter Ksenuk

Senior Clinical Project Manager at Novelion Therapeutics - , ,

Peter Ksenuk's Contact Details
HQ
N/A
Location
Company
Novelion Therapeutics
Peter Ksenuk's Company Details
Novelion Therapeutics logo, Novelion Therapeutics contact details

Novelion Therapeutics

, , • 250 - 499 Employees
Other

Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc. (Aegerion), which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the potential treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development.

N/A
Details about Novelion Therapeutics
Frequently Asked Questions about Peter Ksenuk
Peter Ksenuk currently works for Aegerion Pharmaceuticals.
Peter Ksenuk's role at Aegerion Pharmaceuticals is Senior Clinical Project Manager.
Peter Ksenuk's email address is ***@novelion.com. To view Peter Ksenuk's full email address, please signup to ConnectPlex.
Peter Ksenuk works in the Biotechnology industry.
Peter Ksenuk's colleagues at Novelion Therapeutics are Kristin Kallio, Lisa Collias, Roger Louis, Weger, Mary, Mary Weger, Eileen Rogers, Michael Colacino and others.
Peter Ksenuk's phone number is N/A
See more information about Peter Ksenuk